Back to Search
Start Over
Etiology, Risk Factors, and Management of Asherman Syndrome.
- Source :
-
Obstetrics and gynecology [Obstet Gynecol] 2023 Sep 01; Vol. 142 (3), pp. 543-554. Date of Electronic Publication: 2023 Jul 27. - Publication Year :
- 2023
-
Abstract
- Asherman syndrome is characterized by a triad of symptoms including pain, menstrual abnormalities, and infertility and is a result of intrauterine scar tissue after instrumentation of a gravid uterus. Saline sonohysterogram is typically the most sensitive diagnostic tool; however, hysteroscopy is the criterion standard for diagnosis. Treatment includes hysteroscopic-guided lysis of adhesion, with restoration of the anatomy of the uterine cavity. Several modalities are used in an attempt to reduce the reformation of scar tissue after surgery; however, there is no consensus on the ideal method. Stem cells and platelet-rich plasma are being explored as means of regenerative therapy for the endometrium, but data remain limited. At present, most individuals can have restoration of menstrual function; however, lower pregnancy rates and obstetric complications are not uncommon. These complications are worse for patients with a higher grade of disease. Efforts are needed in standardizing classification, reducing uterine instrumentation of the gravid uterus, and referring patients to health care professionals with clinical expertise in this area.<br />Competing Interests: Financial Disclosure The author did not report any potential conflicts of interest.<br /> (Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-233X
- Volume :
- 142
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Obstetrics and gynecology
- Publication Type :
- Academic Journal
- Accession number :
- 37490750
- Full Text :
- https://doi.org/10.1097/AOG.0000000000005309